DE60222377D1 - Begünstigung der zellwiederherstellung und/oder der zelldifferenzierung mit einem nicht metabolisierbaren zucker und einem polymerischen absorbiermittel - Google Patents

Begünstigung der zellwiederherstellung und/oder der zelldifferenzierung mit einem nicht metabolisierbaren zucker und einem polymerischen absorbiermittel

Info

Publication number
DE60222377D1
DE60222377D1 DE60222377T DE60222377T DE60222377D1 DE 60222377 D1 DE60222377 D1 DE 60222377D1 DE 60222377 T DE60222377 T DE 60222377T DE 60222377 T DE60222377 T DE 60222377T DE 60222377 D1 DE60222377 D1 DE 60222377D1
Authority
DE
Germany
Prior art keywords
cell
affiliating
restoration
polymeric absorbent
metabolizable sugar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60222377T
Other languages
English (en)
Other versions
DE60222377T3 (de
DE60222377T2 (de
Inventor
Daniel Jean
Leon Cariel
Veronique Schwaab
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ueni Medica Fr
Original Assignee
LMD SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8859024&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60222377(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LMD SAS filed Critical LMD SAS
Publication of DE60222377D1 publication Critical patent/DE60222377D1/de
Application granted granted Critical
Publication of DE60222377T2 publication Critical patent/DE60222377T2/de
Publication of DE60222377T3 publication Critical patent/DE60222377T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE60222377T 2001-01-19 2002-01-21 Begünstigung der zellwiederherstellung und/oder der zelldifferenzierung mit einem nicht metabolisierbaren zucker und einem polymerischen absorbiermittel Expired - Lifetime DE60222377T3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0100738 2001-01-19
FR0100738A FR2819721B1 (fr) 2001-01-19 2001-01-19 Traitement des escarres avec sucre non metabolisable et un absorbant polymerique
PCT/FR2002/000228 WO2002056894A1 (fr) 2001-01-19 2002-01-21 Favorisation de la reconstruction cellulaire et/ou de la differenciation cellulaire avec sucre non metabolisable et un absorbant polymerique
EP02700343A EP1351694B2 (de) 2001-01-19 2002-01-21 Begünstigung der zellwiederherstellung und/oder der zelldifferenzierung mit einem nicht metabolisierbaren zucker und einem polymerischen absorbiermittel

Publications (3)

Publication Number Publication Date
DE60222377D1 true DE60222377D1 (de) 2007-10-25
DE60222377T2 DE60222377T2 (de) 2008-06-19
DE60222377T3 DE60222377T3 (de) 2012-01-26

Family

ID=8859024

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60222377T Expired - Lifetime DE60222377T3 (de) 2001-01-19 2002-01-21 Begünstigung der zellwiederherstellung und/oder der zelldifferenzierung mit einem nicht metabolisierbaren zucker und einem polymerischen absorbiermittel

Country Status (18)

Country Link
US (1) US20050191354A1 (de)
EP (1) EP1351694B2 (de)
JP (1) JP2004523521A (de)
KR (1) KR20040018330A (de)
AT (1) ATE372775T1 (de)
CA (1) CA2434608C (de)
CZ (1) CZ305405B6 (de)
DE (1) DE60222377T3 (de)
DK (1) DK1351694T4 (de)
ES (1) ES2292711T5 (de)
FR (1) FR2819721B1 (de)
HU (1) HUP0302816A2 (de)
MX (1) MXPA03006465A (de)
PL (1) PL205732B1 (de)
PT (1) PT1351694E (de)
SI (1) SI1351694T2 (de)
SK (1) SK9262003A3 (de)
WO (1) WO2002056894A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050148101A1 (en) * 1999-01-23 2005-07-07 Bamdad Cynthia C. Interaction of colloid-immobilized species with species on non-colloidal structures
US9314014B2 (en) 2004-02-18 2016-04-19 University Of Maryland, Baltimore Compositions and methods for the storage of red blood cells
KR101374448B1 (ko) * 2005-05-13 2014-03-17 야이즈 스이산가가쿠 고교 가부시키가이샤 피부 재생을 촉진하는 의료용 조성물
US7294350B2 (en) * 2006-03-21 2007-11-13 Marraccini Philip A Healing powder and method of use thereof
AR089518A1 (es) * 2012-12-27 2014-08-27 Vega Villavicencio Parsival Costra artificial porosa semipermeable

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969498A (en) * 1973-09-13 1976-07-13 University Of The Pacific Dressing and method for treating a wound
US4889844A (en) * 1985-10-22 1989-12-26 Silvetti Sr Anthony N Fructose containing wound healing preparation
JPH01203325A (ja) * 1988-02-08 1989-08-16 Takeda Chem Ind Ltd 骨粗鬆症予防治療剤
FR2645741B1 (fr) * 1989-03-20 1995-06-23 Dior Christian Parfums Procede pour fixer un produit sur la membrane d'un keratinocyte au moyen d'une liaison ligand-recepteur, procede de preparation d'un tel produit, produit obtenu, composition cosmetique ou pharmaceutique le contenant et son procede de preparation
US5177065A (en) * 1990-12-26 1993-01-05 Silvetti Sr Anthony N Monosaccharide containing wound healing preparation
US5602183A (en) * 1991-03-01 1997-02-11 Warner-Lambert Company Dermatological wound healing compositions and methods for preparing and using same
ES2248793T3 (es) * 1993-10-01 2006-03-16 Roche Palo Alto Llc Suspensiones orales de alta dosis de mofetil micofenolato.
EP0745392B1 (de) * 1994-02-18 2001-10-24 Kanebo Ltd. Material zur wundbedeckung
US5801116A (en) * 1995-04-07 1998-09-01 Rhodia Inc. Process for producing polysaccharides and their use as absorbent materials
FR2736835B1 (fr) * 1995-07-17 1997-10-10 Aber Technologies Pansement pour plaies chroniques, notamment escarres, en gel de chitine
BR9701968A (pt) * 1997-04-30 1998-12-15 Unilever Nv Composição sinérgica contendo ingredientes umidificantes e absorventes filme ou máscara facial e tratamento facial
JP2854857B2 (ja) * 1997-06-04 1999-02-10 財団法人韓国科学技術研究院 キトサン又は改質キトサンが塗布された白血球除去用フィルタ
JP3472442B2 (ja) * 1997-06-05 2003-12-02 東亜薬品株式会社 損傷皮膚修復用製剤
JP2000038342A (ja) * 1998-05-18 2000-02-08 Kyowa Yakuhin Kogyo Kk 褥瘡・損傷皮膚修復用製剤

Also Published As

Publication number Publication date
EP1351694B2 (de) 2011-07-27
FR2819721B1 (fr) 2005-02-04
EP1351694A1 (de) 2003-10-15
CZ20032011A3 (cs) 2004-02-18
DK1351694T3 (da) 2008-01-14
PT1351694E (pt) 2007-12-20
CA2434608C (fr) 2010-10-26
SI1351694T1 (sl) 2008-02-29
SK9262003A3 (en) 2004-05-04
WO2002056894A1 (fr) 2002-07-25
EP1351694B1 (de) 2007-09-12
SI1351694T2 (sl) 2011-11-30
PL364906A1 (en) 2004-12-27
US20050191354A1 (en) 2005-09-01
FR2819721A1 (fr) 2002-07-26
DK1351694T4 (da) 2011-11-14
CA2434608A1 (fr) 2002-07-25
JP2004523521A (ja) 2004-08-05
ES2292711T5 (es) 2011-12-01
DE60222377T3 (de) 2012-01-26
ES2292711T3 (es) 2008-03-16
DE60222377T2 (de) 2008-06-19
PL205732B1 (pl) 2010-05-31
HUP0302816A2 (hu) 2003-11-28
ATE372775T1 (de) 2007-09-15
CZ305405B6 (cs) 2015-09-02
MXPA03006465A (es) 2004-10-15
KR20040018330A (ko) 2004-03-03

Similar Documents

Publication Publication Date Title
IT1317727B1 (it) Sostanze che assorbono i raggi ultravioletti costituite dabenzotriazoli aventi una aumentata durata.
ATE302686T1 (de) Verbundbahnen mit diskreten elastischen polymerbereichen
FR14C0066I2 (fr) 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles
AU2003284076A1 (en) Feminine care absorbent articles with side barriers against leackage
BR0210005B1 (pt) Polímero, processo para o preparo do mesmo e estrutura absorvente.
EE200200175A (et) Asendatud 2-tio-3,5-ditsüano-4-arüül-6-aminopüridiinid ja nende kasutamine
DE60237851D1 (de) Modifiziertes Propylenpolymer, dieses enthaltende Zusammensetzung und deren Verwendung
DE69921679D1 (de) Rückschlagventil mit platte
DK2277997T3 (da) Polypeptider med cellobiohydrolase I-aktivitet og polynukleotider, der koder for samme
PL1692126T3 (pl) Reaktywne, cykliczne węglany i moczniki do modyfikacji cząsteczek biologicznych, polimerów i powierzchni
ATE225152T1 (de) Windel mit verstellbaren, absorbierenden vorrichtungen
DE602006012475D1 (de) Druckimpulsabschwächung
BR0208971B1 (pt) produto absorvente com ajuste melhorado.
ATE410473T1 (de) Polymerstrukturen mit einem hydrophil/lipophil- system
AU2003219685A8 (en) Ionic superabsorbent polymers with enhanced swelling characteristics
DE60222377D1 (de) Begünstigung der zellwiederherstellung und/oder der zelldifferenzierung mit einem nicht metabolisierbaren zucker und einem polymerischen absorbiermittel
FI20020565A (fi) Kennorakenne, laite ja menetelmä
FR2833599B1 (fr) Polysaccharide amphotere, composition et utilisation
FI20031094A (fi) Xylanaaseja, joilla on lisääntynyt termofiilisyys ja alkalifiilisyys
ITRM950164A0 (it) Derivati della s-trizina, loro preparazione e loro impiego come assorbenti uv (caso 150-5798).
DE59903893D1 (de) Kreisscheibenförmiges Werkzeug mit Stossabsorptionsfähigkeit
DE50014367D1 (de) Gattersäge mit programmgesteuertem schnittgutvorschubförderer
IT1285669B1 (it) Elettrocatetere, in particolare per uso temporaneo
SI1945657T1 (sl) Muteini glikozilacijskih mest tlr in postopki uporabe
DE69915861D1 (de) Vernetzbare, elastische copolymerzusammensetzung

Legal Events

Date Code Title Description
8363 Opposition against the patent
R102 Epo decision maintaining patent in amended form now final

Ref document number: 1351694

Country of ref document: EP

R102 Epo decision maintaining patent in amended form now final

Ref document number: 1351694

Country of ref document: EP

Effective date: 20110727

R082 Change of representative

Ref document number: 1351694

Country of ref document: EP

Representative=s name: SAMSON & PARTNER, PATENTANWAELTE, 80538 MUENCHEN,

R081 Change of applicant/patentee

Ref document number: 1351694

Country of ref document: EP

Owner name: UENI MEDICA, FR

Free format text: FORMER OWNER: LMD, VEYRE MONTON, FR

Effective date: 20111205

R082 Change of representative

Ref document number: 1351694

Country of ref document: EP

Representative=s name: SAMSON & PARTNER, PATENTANWAELTE, 80538 MUENCHEN,